Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications

Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogo...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Santos-Moreno P [verfasserIn] Rodríguez-Vargas GS [verfasserIn] Martínez S [verfasserIn] Ibatá L [verfasserIn] Rojas-Villarraga A [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2022

Schlagwörter:	rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome.

Übergeordnetes Werk:	In: Open Access Rheumatology: Research and Reviews - Dove Medical Press, 2009, (2022), Seite 255-267
Übergeordnetes Werk:	year:2022 ; pages:255-267

Links:	Link aufrufen Link aufrufen Journal toc

Katalog-ID:	DOAJ08360992X

Internformat


LEADER	01000naa a22002652 4500
001	DOAJ08360992X
003	DE-627
005	20230311021949.0
007	cr uuu---uuuuu
008	230311s2022 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)DOAJ08360992X
035			\|a (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RC925-935
100	0		\|a Santos-Moreno P \|e verfasserin \|4 aut
245	1	0	\|a Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications
264		1	\|c 2022
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome
650		4	\|a rheumatoid arthritis
650		4	\|a metabolic diseases
650		4	\|a cardiovascular diseases
650		4	\|a metabolic syndrome.
653		0	\|a Diseases of the musculoskeletal system
700	0		\|a Rodríguez-Vargas GS \|e verfasserin \|4 aut
700	0		\|a Martínez S \|e verfasserin \|4 aut
700	0		\|a Ibatá L \|e verfasserin \|4 aut
700	0		\|a Rojas-Villarraga A \|e verfasserin \|4 aut
773	0	8	\|i In \|t Open Access Rheumatology: Research and Reviews \|d Dove Medical Press, 2009 \|g (2022), Seite 255-267 \|w (DE-627)606032002 \|w (DE-600)2508169-X \|x 1179156X \|7 nnns
773	1	8	\|g year:2022 \|g pages:255-267
856	4	0	\|u https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 \|z kostenfrei
856	4	0	\|u https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1179-156X \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|j 2022 \|h 255-267

Indexfelder

author_variant	s m p smp r v g rvg m s ms i l il r v a rva
matchkey_str	article:1179156X:2022----::eaoianraiisadoaclriesadeaoisnrmiauthuaodrhiiptetcre
hierarchy_sort_str	2022
callnumber-subject-code	RC
publishDate	2022
allfields	(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 DE-627 ger DE-627 rakwb eng RC925-935 Santos-Moreno P verfasserin aut Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system Rodríguez-Vargas GS verfasserin aut Martínez S verfasserin aut Ibatá L verfasserin aut Rojas-Villarraga A verfasserin aut In Open Access Rheumatology: Research and Reviews Dove Medical Press, 2009 (2022), Seite 255-267 (DE-627)606032002 (DE-600)2508169-X 1179156X nnns year:2022 pages:255-267 https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 kostenfrei https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR kostenfrei https://doaj.org/toc/1179-156X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2022 255-267
spelling	(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 DE-627 ger DE-627 rakwb eng RC925-935 Santos-Moreno P verfasserin aut Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system Rodríguez-Vargas GS verfasserin aut Martínez S verfasserin aut Ibatá L verfasserin aut Rojas-Villarraga A verfasserin aut In Open Access Rheumatology: Research and Reviews Dove Medical Press, 2009 (2022), Seite 255-267 (DE-627)606032002 (DE-600)2508169-X 1179156X nnns year:2022 pages:255-267 https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 kostenfrei https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR kostenfrei https://doaj.org/toc/1179-156X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2022 255-267
allfields_unstemmed	(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 DE-627 ger DE-627 rakwb eng RC925-935 Santos-Moreno P verfasserin aut Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system Rodríguez-Vargas GS verfasserin aut Martínez S verfasserin aut Ibatá L verfasserin aut Rojas-Villarraga A verfasserin aut In Open Access Rheumatology: Research and Reviews Dove Medical Press, 2009 (2022), Seite 255-267 (DE-627)606032002 (DE-600)2508169-X 1179156X nnns year:2022 pages:255-267 https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 kostenfrei https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR kostenfrei https://doaj.org/toc/1179-156X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2022 255-267
allfieldsGer	(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 DE-627 ger DE-627 rakwb eng RC925-935 Santos-Moreno P verfasserin aut Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system Rodríguez-Vargas GS verfasserin aut Martínez S verfasserin aut Ibatá L verfasserin aut Rojas-Villarraga A verfasserin aut In Open Access Rheumatology: Research and Reviews Dove Medical Press, 2009 (2022), Seite 255-267 (DE-627)606032002 (DE-600)2508169-X 1179156X nnns year:2022 pages:255-267 https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 kostenfrei https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR kostenfrei https://doaj.org/toc/1179-156X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2022 255-267
allfieldsSound	(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 DE-627 ger DE-627 rakwb eng RC925-935 Santos-Moreno P verfasserin aut Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system Rodríguez-Vargas GS verfasserin aut Martínez S verfasserin aut Ibatá L verfasserin aut Rojas-Villarraga A verfasserin aut In Open Access Rheumatology: Research and Reviews Dove Medical Press, 2009 (2022), Seite 255-267 (DE-627)606032002 (DE-600)2508169-X 1179156X nnns year:2022 pages:255-267 https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 kostenfrei https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR kostenfrei https://doaj.org/toc/1179-156X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2022 255-267
language	English
source	In Open Access Rheumatology: Research and Reviews (2022), Seite 255-267 year:2022 pages:255-267
sourceStr	In Open Access Rheumatology: Research and Reviews (2022), Seite 255-267 year:2022 pages:255-267
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system
isfreeaccess_bool	true
container_title	Open Access Rheumatology: Research and Reviews
authorswithroles_txt_mv	Santos-Moreno P @@aut@@ Rodríguez-Vargas GS @@aut@@ Martínez S @@aut@@ Ibatá L @@aut@@ Rojas-Villarraga A @@aut@@
publishDateDaySort_date	2022-01-01T00:00:00Z
hierarchy_top_id	606032002
id	DOAJ08360992X
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ08360992X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230311021949.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ08360992X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJc395e6e1b57e47878bcd254baf37e214</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC925-935</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Santos-Moreno P</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">rheumatoid arthritis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metabolic diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cardiovascular diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metabolic syndrome.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the musculoskeletal system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rodríguez-Vargas GS</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Martínez S</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ibatá L</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rojas-Villarraga A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Open Access Rheumatology: Research and Reviews</subfield><subfield code="d">Dove Medical Press, 2009</subfield><subfield code="g">(2022), Seite 255-267</subfield><subfield code="w">(DE-627)606032002</subfield><subfield code="w">(DE-600)2508169-X</subfield><subfield code="x">1179156X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2022</subfield><subfield code="g">pages:255-267</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1179-156X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2022</subfield><subfield code="h">255-267</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Santos-Moreno P
spellingShingle	Santos-Moreno P misc RC925-935 misc rheumatoid arthritis misc metabolic diseases misc cardiovascular diseases misc metabolic syndrome. misc Diseases of the musculoskeletal system Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications
authorStr	Santos-Moreno P
ppnlink_with_tag_str_mv	@@773@@(DE-627)606032002
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC925-935
illustrated	Not Illustrated
issn	1179156X
topic_title	RC925-935 Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome
topic	misc RC925-935 misc rheumatoid arthritis misc metabolic diseases misc cardiovascular diseases misc metabolic syndrome. misc Diseases of the musculoskeletal system
topic_unstemmed	misc RC925-935 misc rheumatoid arthritis misc metabolic diseases misc cardiovascular diseases misc metabolic syndrome. misc Diseases of the musculoskeletal system
topic_browse	misc RC925-935 misc rheumatoid arthritis misc metabolic diseases misc cardiovascular diseases misc metabolic syndrome. misc Diseases of the musculoskeletal system
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Open Access Rheumatology: Research and Reviews
hierarchy_parent_id	606032002
hierarchy_top_title	Open Access Rheumatology: Research and Reviews
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)606032002 (DE-600)2508169-X
title	Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications
ctrlnum	(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214
title_full	Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications
author_sort	Santos-Moreno P
journal	Open Access Rheumatology: Research and Reviews
journalStr	Open Access Rheumatology: Research and Reviews
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2022
contenttype_str_mv	txt
container_start_page	255
author_browse	Santos-Moreno P Rodríguez-Vargas GS Martínez S Ibatá L Rojas-Villarraga A
class	RC925-935
format_se	Elektronische Aufsätze
author-letter	Santos-Moreno P
author2-role	verfasserin
title_sort	metabolic abnormalities, cardiovascular disease, and metabolic syndrome in adult rheumatoid arthritis patients: current perspectives and clinical implications
callnumber	RC925-935
title_auth	Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications
abstract	Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome
abstractGer	Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome
abstract_unstemmed	Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
title_short	Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications
url	https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR https://doaj.org/toc/1179-156X
remote_bool	true
author2	Rodríguez-Vargas GS Martínez S Ibatá L Rojas-Villarraga A
author2Str	Rodríguez-Vargas GS Martínez S Ibatá L Rojas-Villarraga A
ppnlink	606032002
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
callnumber-a	RC925-935
up_date	2024-07-03T18:25:35.520Z
_version_	1803583367961116672
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ08360992X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230311021949.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ08360992X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJc395e6e1b57e47878bcd254baf37e214</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC925-935</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Santos-Moreno P</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">rheumatoid arthritis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metabolic diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cardiovascular diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metabolic syndrome.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the musculoskeletal system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rodríguez-Vargas GS</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Martínez S</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ibatá L</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rojas-Villarraga A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Open Access Rheumatology: Research and Reviews</subfield><subfield code="d">Dove Medical Press, 2009</subfield><subfield code="g">(2022), Seite 255-267</subfield><subfield code="w">(DE-627)606032002</subfield><subfield code="w">(DE-600)2508169-X</subfield><subfield code="x">1179156X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2022</subfield><subfield code="g">pages:255-267</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1179-156X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2022</subfield><subfield code="h">255-267</subfield></datafield></record></collection>
score	7.400529

Nicht das Richtige dabei?

Schreiben Sie uns!

Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?